Rehovot, Israel

Xtl Biopharmaceuticals Ltd.


USPTO Granted Patents = 8

Forward Citations = 41

Loading Chart...
Loading Chart...

17 inventors (with patents filed for the assignee):

goldMedal Reza Fathi (6 out of 41 patents)

silverMedal Zhen Yang (6 out of 13 patents)

bronzeMedal Yixin Liu (5 out of 5 patents)

4 Anthony Sandrasagra (5 out of 5 patents)

5 Qiang Zhu (4 out of 5 patents)

6 Yun Liao (3 out of 4 patents)

7 Kenneth Nawoschik (3 out of 3 patents)

8 Hyun-Joon Cho (3 out of 3 patents)

9 Youhong Hu (2 out of 2 patents)

10 Bin Xu (2 out of 2 patents)

11 C Richard Wobbe (2 out of 11 patents)

12 Shlomo Dagan (2 out of 6 patents)

13 Guolin Li (1 out of 1 patent)

14 Angela Lam (1 out of 1 patent)

15 Jie Cao (1 out of 1 patent)


8 patents:

XTL Biopharmaceuticals is a clinical-stage biopharmaceutical company focused on the acquisition, development, and commercialization of pharmaceutical products for the treatment of autoimmune diseases. The company's lead product candidate is hCDR1, a treatment for systemic lupus erythematosus.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

8 Patents

#34 in Rehovot

#755 in Israel

...
Rehovot, Israel
Forward Citations = 41

17 inventors:

Please report any incorrect information to support@idiyas.com
Loading…